Status:
COMPLETED
Leap Motion Controller on the Functionality of Upper Limbs in Parkinson's Disease
Lead Sponsor:
Federal University of Health Science of Porto Alegre
Conditions:
Parkinson Disease
Upper Extremity Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Is treatment with the Leap Motion Controller device effective for upper limb functionality in individuals with Parkinson's Disease? The present study presents two hypotheses: True hypothesis: There ...
Detailed Description
STUDY METHODOLOGY 1. RESEARCH DESIGN: The proposed work will be characterized as a Randomized Clinical Trial, with evaluators outside the experimental groups (single-blind). The sample will be probab...
Eligibility Criteria
Inclusion
- Parkinson's disease diagnostic;
- Classified as I-III on the Hoehn \& Yahr motor staging scale;
- Are over 18 years old (above this, without age restriction).
- Residents in the city of Porto Alegre / RS.
- Have signed an informed consent form.
Exclusion
- Do not show the understanding of the games on the first day of familiarization;
- Have a cerebral pacemaker implant;
- Have recent injuries or limitations that make the MMSS impossible.
- Do not perform / abstain from two appointments out of the 16 proposed in the intervention protocol, regardless of the group that will be allocated.
Key Trial Info
Start Date :
January 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04796246
Start Date
January 15 2022
End Date
August 1 2023
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philipe Souza Correa
Porto Alegre, Rio Grande do Sul, Brazil, 55